| NDC Code | 0093-5292-01 |
|---|
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-5292-01) |
|---|
| Product NDC | 0093-5292 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Methylphenidate Hydrochloride |
|---|
| Proprietary Name Suffix | (cd) |
|---|
| Non-Proprietary Name | Methylphenidate Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20120927 |
|---|
| End Marketing Date | 20241031 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA078873 |
|---|
| Manufacturer | Teva Pharmaceuticals USA, Inc. |
|---|
| Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
|---|
| Strength | 50 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE] |
|---|
| DEA Schedule | CII |
|---|